Luca Arecco/X
Jun 14, 2025, 09:02
Luca Arecco: Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies
Luca Arecco, Clinical Research Fellow at ESMO, shared a post on X:
“In the era of immunotherapy and targeted agents, oncofertility and reproductive counselling after cancer are becoming increasingly complex. In our latest review in Human Reproduction we address major evidence in this field.
Thank you Matteo Lambertini and all coauthors.”
Title: Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies
Authors: Luca Arecco , Luciana de Moura Leite , Gabriella Gentile , Kristina Jankovic , Mihaela Stana , Silvia Ottonello , Graziana Scavone , Stefano Spinaci , Matteo Lambertini
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 14, 2025, 07:19